Congress blocks 'most favored nation' drug pricing legislation by 2027

Pharma leaders and Republican lawmakers oppose the 'most favored nation' pricing policy, citing concerns over free-market principles and potential drug rationing. Industry pressure and Republican opposition make passage unlikely.

Implied probability (Yes)

80%